Potomac advises Merieux Equity Partners on the merger of Plantex with Nactarome
Founded in 1990, Plantex is the French leader in plant extracts for the nutraceutical market, generating over €30 millions in revenue.
Operating in more than 45 countries, the group serves four key markets :
1) health & nutrition
2) food & beverage
3) animal nutrition
4) cosmetics
With full control of its value chain from sourcing, manufacturing, and quality assurance to certification – Plantex offers a wide range of more than 1,300 references and has unique expertise in organic products and customized plant extracts.
Under the majority investment of Mérieux Equity Partners, a healthcare private equity firm, the group has experienced strong growth, particularly internationally, which now accounts for over 60% of its turnover, while also strengthening its industrial capabilities.
Building on this momentum, Plantex merges with Nactarome, the Italian leader in natural colors, flavors, and ingredients, to create a European champion in health and nutrition.
Nactarome, backed by the U.S. investment fund TA Associates, a major player in the ingredients sector gains privileged access to the nutraceutical market, combining strong scientific expertise with significant customer and geographical synergies.



